Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Jul 19, 2017 (9 years ago)

Voriconazole Tablets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed impurities/degradation specifications: Out of specification for a related compound C.

Cause type: Impurity / degradation

An impurity or degradation product above its limit - other than nitrosamines. Unexpected substances in a batch can make it unsafe or less effective, even when the active ingredient is present. All impurity / degradation recalls.

What was recalled

Voriconazole Tablets, 200 mg, 20-count cartons (4 x 5) Unit Dose, Rx only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 50268-804-12

Affected NDC 50268-0804-12

Compare with the code on your package — it is the most precise check available.

Drug: Voriconazole

Recalling firm
AVKARE Inc.
NDC code
50268-804-12
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1094-2017 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Voriconazole recalls

See all
Class II · Moderate risk

Voriconazole Tablets

cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.

Terminated cGMP deviation Amerisource Health Services LLC NDC 60687-294-21 D-0307-2025

Other recalls by AVKARE Inc.

All 2017 recalls
Class II · Moderate risk

Amantadine HCl

Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.

Ongoing Dissolution failure AvKARE NDC 50268-069-15 D-0341-2026